logo

For the Inventor, By the Inventor

Mannheim-Seckenheim, Germany

Felix Helmut Schmidt

USPTO Granted Patents = 13

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 147(Granted Patents)


Location History:

  • Mannheim-Seckenheim, DE (1976 - 1980)
  • Mannheim, DE (1984)

Company Filing History:

goldMedal13 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents

Years Active: 1976-1984

Loading Chart...
13 patents (USPTO):Explore Patents
1. 4425360 - Pharmacologically active novel O-substituted pyruvic acid oximes (1984-01-10),
2. 4238506 - Hypoglycaemically and hypolipidaemically active derivatives of (1980-12-09),
3. 4206231 - Hypoglycaemically active 2-alkyl- or -alkenyl-hydrazono propionic acid (1980-06-03),
4. 4136197 - Hypoglycaemically and hypolipidaemically effective n-substituted (1979-01-23),
5. 4113871 - Hypoglycemically and hypolipidemically active derivatives of (1978-09-12),
6. 4060634 - Rapidly resorbable glibenclamide (1977-11-29),
7. 4060626 - Indole-carboxylic carbon compounds and pharmaceutical compositions (1977-11-29),
8. 4053624 - Indole-2-carbaldehyde compounds and blood sugar reducing compositions (1977-10-11),
9. 4017539 - Biguanide compounds and anti-diabetic compositions (1977-04-12),
10. 3996241 - 2-Hydroxymethyl indole compounds and blood sugar lowering compositions (1976-12-07),
11. 3988317 - Heterocyclic-substituted nebularin compounds (1976-10-26),
12. 3979520 - Preparation of rapidly resorbable glibenclamide (1976-09-07),
13. 3966916 - N(6)-disubstituted adenoisine compounds and therapeutic compositions (1976-06-29),

Title: Felix Helmut Schmidt: Innovator in Pharmaceutical Chemistry

Introduction

Felix Helmut Schmidt is a notable inventor based in Mannheim-Seckenheim, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds aimed at treating various medical conditions. With a total of 13 patents to his name, Schmidt's work has had a considerable impact on the industry.

Latest Patents

One of Schmidt's latest patents involves pharmacologically active novel O-substituted pyruvic acid oximes. This invention provides pyruvic acid oximes of a specific general formula, which includes various substituents that enhance their therapeutic potential. The compounds are designed to combat hypoglycemia and include processes for their preparation, pharmaceutical compositions containing them, and their applications in medical treatments. Additionally, he has developed hypoglycaemically and hypolipidaemically active derivatives of phenyl-alkane-carboxylic acids, showcasing his innovative approach to drug development.

Career Highlights

Felix Helmut Schmidt has been associated with Boehringer Mannheim GmbH, a prominent company in the pharmaceutical sector. His work at this organization has allowed him to focus on research and development, leading to the creation of impactful pharmaceutical products. His dedication to innovation in drug formulation has positioned him as a key figure in his field.

Collaborations

Throughout his career, Schmidt has collaborated with notable colleagues, including Ruth Heerdt and Manfred Hubner. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and scope of his research.

Conclusion

Felix Helmut Schmidt's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the field. His work continues to influence the development of new treatments, showcasing the vital role of inventors in advancing healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…